...
首页> 外文期刊>Medical science monitor : >Low Paraoxonase 1 Arylesterase Activity and High von Willebrand Factor Levels are Associated with Severe Coronary Atherosclerosis in Patients with Non-Diabetic Stable Coronary Artery Disease
【24h】

Low Paraoxonase 1 Arylesterase Activity and High von Willebrand Factor Levels are Associated with Severe Coronary Atherosclerosis in Patients with Non-Diabetic Stable Coronary Artery Disease

机译:非糖尿病稳定性冠状动脉疾病患者的低对氧磷酶1芳基酯酶活性和高von Willebrand因子水平与严重的冠状动脉粥样硬化相关

获取原文

摘要

Background Paraoxonase 1 (PON1) activity and von Willebrand factor (VWF) release are associated with lesion initiation in atherosclerosis. Diabetes can complicate coronary artery disease (CAD) due to the production of advanced glycation end products. This study evaluated PON1 activity and VWF levels in non-post-acute coronary syndrome, stable CAD (SCAD) patients without diabetes. Material and Methods Non-diabetic SCAD patients and patients experiencing acute stress periods were selected (n=130). Forty-seven cases with normal coronary angiography and 50 healthy individuals served as controls. The non-diabetic SCAD group was then stratified into single-vessel lesions, multiple-vessel lesions, and mild or severe luminal stenosis according to the number and the degree of luminal stenoses. Serum PON1 paraoxonase and arylesterase activities, and plasma VWF levels were measured, as well as serum total cholesterol, total triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and apolipoprotein A1. PON1 arylesterase activity was detected with an ordinary chemistry system using a novel phenylacetate derivative. Results Both PON1 paraoxonase and arylesterase were lower in the non-diabetic SCAD group, but VWF levels were higher (versus controls, all P<0.001). PON1 paraoxonase activity (OR=0.991), PON1 arylesterase activity (OR=0.981), and VWF (OR 2.854) influenced SCAD in multiple logistic regression. Decreased PON1 arylesterase activity and increased VWF levels were associated with severe atherosclerosis in non-diabetic SCAD patients. We also observed a slight negative correlation between VWF and PON1 paraoxonase/arylesterase. Conclusions PON1 and VWF are detectable markers that may predict the severity of stenoses, ideally facilitating a non-diabetic SCAD diagnosis before the sudden onset of life-threatening symptoms.
机译:背景对氧磷酶1(PON1)活性和血管性血友病因子(VWF)释放与动脉粥样硬化中的病变起始有关。由于晚期糖基化终产物的产生,糖尿病可使冠状动脉疾病(CAD)复杂化。这项研究评估了非糖尿病急性冠脉综合征,稳定型CAD(SCAD)患者的PON1活性和VWF水平。材料和方法选择非糖尿病SCAD患者和经历急性应激期的患者(n = 130)。 47例正常冠状动脉造影和50例健康个体作为对照。然后,根据管腔狭窄的数量和程度,将非糖尿病性SCAD组分为单支血管病变,多支血管病变以及轻度或重度管腔狭窄。测量了血清PON1对氧磷酶和芳基酯酶的活性,以及​​血浆VWF的水平,以及血清总胆固醇,总甘油三酸酯,高密度脂蛋白胆固醇,低密度脂蛋白胆固醇和载脂蛋白A1。 PON1芳基酯酶活性是使用新的乙酸苯酯衍生物通过常规化学系统检测的。结果非糖尿病SCAD组的PON1对氧磷酶和芳基酯酶均较低,但VWF水平较高(与对照组相比,所有P <0.001)。 PON1对氧磷酶活性(OR = 0.991),PON1芳基酯酶活性(OR = 0.981)和VWF(OR 2.854)在多重逻辑回归中影响SCAD。非糖尿病SCAD患者的PON1芳基酯酶活性降低和VWF水平升高与严重的动脉粥样硬化有关。我们还观察到VWF和PON1对氧磷酶/芳基酯酶之间存在轻微的负相关。结论PON1和VWF是可检测的标志物,可预测狭窄的严重程度,理想地有助于在威胁生命的症状突然发作之前进行非糖尿病性SCAD诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号